Phase II study of avelumab in combination with cetuximab as a rechallenge strategy in pre-treated RAS wild type metastatic colorectal cancer patients: CAVE (cetuximab-avelumab) colon
Saved in:
Published in | Annals of oncology Vol. 30; p. v251 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.10.2019
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0923-7534 |
---|---|
DOI: | 10.1093/annonc/mdz246.145 |